DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists

INTRODUCTION: No definitive data are available regarding the value of switching to an alternative TNF antagonist in rheumatoid arthritis patients who fail to respond to the first one. The aim of this study was to evaluate treatment response in a clinical setting based on HAQ improvement and EULAR re...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Sarabia, Federico, Ruiz-Montesinos, Dolores, Hernandez, Blanca, Navarro-Compán, Victoria, Marsal, Sara, Barcelo, Mireia, Perez-Pampín, Eva, Gómez-Reino, Juan J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724400/
https://www.ncbi.nlm.nih.gov/pubmed/19627609
http://dx.doi.org/10.1186/1471-2474-10-91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724400/
https://www.ncbi.nlm.nih.gov/pubmed/19627609
http://dx.doi.org/10.1186/1471-2474-10-91

Ejemplares similares